Image‐guided percutaneous cryoablation of unresectable sacrococcygeal chordoma: Feasibility and outcome in a selected group of patients with long term follow‐up
Autor: | Aurélien Traverso, Nicolas Gallusser, Igor Letovanec, Patrick Goetti, Hafize Heutschi-Ozturk, Stéphane Cherix, Pierre Bize, Sami Abou-Khalil, Alexander A Bazan, Michael Montemurro |
---|---|
Rok vydání: | 2020 |
Předmět: |
Adult
Male medicine.medical_specialty Long term follow up medicine.medical_treatment Cryosurgery 03 medical and health sciences 0302 clinical medicine Chordoma medicine Humans Survival rate Aged Retrospective Studies Percutaneous cryoablation Sacrococcygeal Region business.industry Patient Selection Retrospective cohort study General Medicine Middle Aged Prognosis medicine.disease Survival Rate Radiation therapy Oncology 030220 oncology & carcinogenesis Cohort Feasibility Studies Surgery Female 030211 gastroenterology & hepatology Radiology Neoplasm Recurrence Local business Sacrococcygeal chordoma Follow-Up Studies |
Zdroj: | Journal of Surgical Oncology, vol. 123, no. 2, pp. 497-504 |
ISSN: | 1096-9098 0022-4790 |
DOI: | 10.1002/jso.26288 |
Popis: | Background Chordoma is a rare malignant tumor of the axial skeleton. Percutaneous cryoablation (PCA) is a minimally invasive technique that allows freezing of tumors under imaging control. The purpose of our retrospective study was to investigate the outcome of PCA in a selected cohort of patients with sacrococcygeal chordoma, with a minimum of 5 years follow-up. Materials and methods Four patients were treated in 10 sessions. The mean follow-up was 57.3 months. We evaluated the feasibility, the procedure-related complications, the impact on pain control and oncological outcomes. Results Freezing of 100% of the tumor volume was possible in 60%. Pain control was not reliably evaluable. Local recurrence occurred in 90% of the treated lesions; the mean time to progression was 8.1 months (range 1.5-16). At last follow-up, one patient had died of the disease, one of another cause and one was receiving the best supportive care. The only patient alive without the disease had received additional carbon-ion radiotherapy. The 5-year survival rate after index PCA was 50%. Conclusion Complete freezing of the tumor was technically challenging, mainly due to the complex local anatomy. Recurrence occurred in 90% of the lesions treated. PCA should be considered with caution in the curative management of sacrococcygeal chordoma. |
Databáze: | OpenAIRE |
Externí odkaz: |